In patients treated with IL-2/ IFN alpha -based therapy , relative levels of TCRzeta increased significantly ( P = 0 . 002 ) on day 15 of cycle one compared with the baseline .
in patients treated with il-2/ ifn alpha -based therapy , relative levels of tcrzeta increased significantly ( p = 0 . 002 ) on day 15 of cycle one compared with the baseline .
O B-multi_cell O O O B-protein_molecule I-protein_molecule O O O O O O B-protein_molecule O O O O O O O O O O O O O O O O O O O O